ArticleBMC cancer2017

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.

K Lisenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.